How does MM2's PS Ratio compare to its peers?

MM2 is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (2.3x).

How does MM2's PS Ratio compare vs other companies in the DE Medical Equipment Industry?

MM2 is good value based on its Price-To-Sales Ratio (1.1x) compared to the European Medical Equipment industry average (3.7x).

What is MM2's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate MM2's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of MM2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

MM2 (€13.9) is trading above our estimate of [[fair value]] (€12.18)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

MM2 Stock Overview

Manufactures and distributes disposable medical gloves, dressings, and non-woven fabric products in Poland, the Czech Republic, Ukraine, France, Hungary, Italy, Romania, Germany, rest of Europe, and Thailand. More details

MM2 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	2/6

Risk Analysis

Shares are highly illiquid

Earnings have declined by 32.6% per year over past 5 years

Dividend of 4.64% is not well covered by earnings or free cash flows

My Notes

Capture your thoughts, links and company narrative

Mercator Medical S.A. Competitors

Paul Hartmann

DB:PHH2

€806.2m

PULSION Medical Systems

MUN:PUS

€131.9m

MEDICLIN

XTRA:MED

€114.0m

NanoRepro

XTRA:NN6

€18.7m

Price History & Performance

Summary of share price highs, lows and changes for Mercator Medical
Historical stock prices
Current Share Price	zł13.90
52 Week High	zł14.38
52 Week Low	zł13.16
Beta	2.61
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-90.25%

Recent updates

Shareholder Returns

	MM2	DE Medical Equipment	DE Market
7D	0%	2.1%	2.0%
1Y	n/a	-7.9%	9.6%

Return vs Industry: Insufficient data to determine how MM2 performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how MM2 performed against the German Market.

Price Volatility

Is MM2's price volatile compared to industry and market?
MM2 volatility
MM2 Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.5%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.7%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: MM2's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine MM2's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1989	800	Monika Zyznowska	mercatormedical.eu

Mercator Medical S.A., together with its subsidiaries, manufactures and distributes disposable medical gloves, dressings, and non-woven fabric products in Poland, the Czech Republic, Ukraine, France, Hungary, Italy, Romania, Germany, rest of Europe, and Thailand. The company offers surgical and protective, sterile examination and protective, and household gloves; glove brackets; and household and protective – professional products, including caps, masks, gowns, shoe covers, surgical shirts, and sleeve protectors. The company markets its products under the nitrylex, opero, MERCATOR, Ansell, dermagel, santex, comfort, vinylex, iNtouch, ambulance, and ideal brands.

Mercator Medical S.A. Fundamentals Summary

How do Mercator Medical's earnings and revenue compare to its market cap?
MM2 fundamental statistics
Market cap	€123.51m
Earnings (TTM)	-€568.28k
Revenue (TTM)	€114.64m

1.1x

P/S Ratio

-217.3x

P/E Ratio

Is MM2 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MM2 income statement (TTM)
Revenue	zł488.78m
Cost of Revenue	zł369.11m
Gross Profit	zł119.67m
Other Expenses	zł122.09m
Earnings	-zł2.42m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.25
Gross Margin	24.48%
Net Profit Margin	-0.50%
Debt/Equity Ratio	0.01%

How did MM2 perform over the long term?

See historical performance and comparison

Dividends

4.6%

Current Dividend Yield

-10%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/08 19:55
End of Day Share Price	2024/10/15 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Mercator Medical S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tomasz Rodak	Dom Maklerski Banku Ochrony Srodowiska S.A.
Dawid Górzynski	PKO BP Securities
Aleksandra Jakubowska	Vestor Dom Maklerski SA